Aspect Biosystems receives funding for cellular medicine project
Pharmaceutical Business Review
The project will enhance Aspect Biosystems' clinical development capabilities and bolster its integrated platform for developing and manufacturing advanced cellular medicines.
pharminent
April 6, 2026 (Last updated: April 6, 2026)
Pharmaceutical Business Review
The project will enhance Aspect Biosystems’ clinical development capabilities and bolster its integrated platform for developing and manufacturing advanced cellular medicines.